annual SGA:
$307.98M+$27.81M(+9.93%)Summary
- As of today (May 31, 2025), ASND annual SGA is $307.98 million, with the most recent change of +$27.81 million (+9.93%) on December 31, 2024.
- During the last 3 years, ASND annual SGA has risen by +$118.46 million (+62.50%).
- ASND annual SGA is now at all-time high.
Performance
ASND SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$106.32M+$22.35M(+26.61%)Summary
- As of today (May 31, 2025), ASND quarterly SGA is $106.32 million, with the most recent change of +$22.35 million (+26.61%) on March 31, 2025.
- Over the past year, ASND quarterly SGA has increased by +$33.78 million (+46.57%).
- ASND quarterly SGA is now at all-time high.
Performance
ASND quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
-$5.72B(NaN%)Summary
- As of today (May 31, 2025), ASND TTM SGA is -$5.72 billion
- Over the past year, ASND TTM SGA has dropped by -$6.01 billion (-2113.65%).
- ASND TTM SGA is now -1127.95% below its all-time high of $556.61 million.
Performance
ASND TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ASND Selling, general & administrative expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +9.9% | +46.6% | -2113.7% |
3 y3 years | +62.5% | +99.8% | -2998.9% |
5 y5 years | +467.5% | +437.8% | -9311.9% |
ASND Selling, general & administrative expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +62.5% | at high | +103.2% | -238.0% | at low |
5 y | 5-year | at high | +467.5% | at high | +437.8% | -238.0% | at low |
alltime | all time | at high | +9498.2% | at high | >+9999.0% | -1128.0% | at low |
ASND Selling, general & administrative expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | $106.32M(+26.6%) | $345.24M(+10.8%) |
Dec 2024 | $307.98M(+9.9%) | $83.98M(+12.1%) | $311.46M(+5.8%) |
Sep 2024 | - | $74.93M(-6.4%) | $294.39M(+2.4%) |
Jun 2024 | - | $80.02M(+10.3%) | $287.52M(+1.2%) |
Mar 2024 | - | $72.54M(+8.4%) | $284.14M(+0.4%) |
Dec 2023 | $280.17M(+23.1%) | $66.90M(-1.7%) | $283.07M(+5.4%) |
Sep 2023 | - | $68.06M(-11.2%) | $268.49M(+2.7%) |
Jun 2023 | - | $76.64M(+7.2%) | $261.55M(+6.7%) |
Mar 2023 | - | $71.47M(+36.6%) | $245.18M(+8.0%) |
Dec 2022 | $227.63M(+20.1%) | $52.33M(-14.4%) | $226.93M(-1.3%) |
Sep 2022 | - | $61.12M(+1.4%) | $229.84M(+6.9%) |
Jun 2022 | - | $60.27M(+13.3%) | $215.04M(+9.0%) |
Mar 2022 | - | $53.21M(-3.7%) | $197.37M(+4.4%) |
Dec 2021 | $189.52M(+116.5%) | $55.25M(+19.3%) | $189.04M(+19.5%) |
Sep 2021 | - | $46.32M(+8.7%) | $158.15M(+19.5%) |
Jun 2021 | - | $42.60M(-5.1%) | $132.33M(+17.5%) |
Mar 2021 | - | $44.88M(+84.3%) | $112.64M(+28.7%) |
Dec 2020 | $87.56M(+61.4%) | $24.35M(+18.8%) | $87.53M(+6.6%) |
Sep 2020 | - | $20.49M(-10.6%) | $82.08M(+12.9%) |
Jun 2020 | - | $22.91M(+15.9%) | $72.71M(+17.1%) |
Mar 2020 | - | $19.77M(+4.5%) | $62.11M(+14.6%) |
Dec 2019 | $54.27M | $18.91M(+70.1%) | $54.20M(+20.9%) |
Sep 2019 | - | $11.12M(-9.7%) | $44.84M(+7.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2019 | - | $12.31M(+3.9%) | $41.62M(+17.1%) |
Mar 2019 | - | $11.85M(+24.1%) | $35.55M(+20.8%) |
Dec 2018 | $29.59M(+93.8%) | $9.55M(+20.9%) | $29.42M(+19.2%) |
Sep 2018 | - | $7.90M(+26.6%) | $24.68M(+22.7%) |
Jun 2018 | - | $6.24M(+9.0%) | $20.12M(+15.4%) |
Mar 2018 | - | $5.73M(+19.0%) | $17.43M(+14.3%) |
Dec 2017 | $15.27M(+19.9%) | $4.81M(+44.1%) | $15.25M(+9.1%) |
Sep 2017 | - | $3.34M(-6.1%) | $13.98M(+2.9%) |
Jun 2017 | - | $3.56M(+0.4%) | $13.59M(+4.1%) |
Mar 2017 | - | $3.54M(-0.1%) | $13.05M(+2.6%) |
Dec 2016 | $12.73M(+21.9%) | $3.54M(+20.3%) | $12.72M(-1.9%) |
Sep 2016 | - | $2.95M(-2.2%) | $12.97M(+12.1%) |
Jun 2016 | - | $3.02M(-6.0%) | $11.57M(+5.9%) |
Mar 2016 | - | $3.21M(-15.5%) | $10.93M(+4.7%) |
Dec 2015 | $10.45M(+25.2%) | $3.80M(+144.7%) | $10.43M(+8.8%) |
Sep 2015 | - | $1.55M(-34.5%) | $9.59M(-5.1%) |
Jun 2015 | - | $2.37M(-12.7%) | $10.10M(+4.5%) |
Mar 2015 | - | $2.71M(-8.2%) | $9.66M(+17.2%) |
Dec 2014 | $8.34M(+160.0%) | $2.95M(+43.3%) | $8.24M(+36.5%) |
Sep 2014 | - | $2.06M(+6.9%) | $6.04M(+51.9%) |
Jun 2014 | - | $1.93M(+49.1%) | $3.98M(+94.3%) |
Mar 2014 | - | $1.29M(+72.3%) | $2.05M(+172.3%) |
Dec 2013 | $3.21M(-7.2%) | $751.40K | $751.40K |
Dec 2012 | $3.46M | - | - |
FAQ
- What is Ascendis Pharma A/S annual SGA?
- What is the all time high annual SGA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual SGA year-on-year change?
- What is Ascendis Pharma A/S quarterly SGA?
- What is the all time high quarterly SGA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly SGA year-on-year change?
- What is Ascendis Pharma A/S TTM SGA?
- What is the all time high TTM SGA for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM SGA year-on-year change?
What is Ascendis Pharma A/S annual SGA?
The current annual SGA of ASND is $307.98M
What is the all time high annual SGA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual SGA is $307.98M
What is Ascendis Pharma A/S annual SGA year-on-year change?
Over the past year, ASND annual SGA has changed by +$27.81M (+9.93%)
What is Ascendis Pharma A/S quarterly SGA?
The current quarterly SGA of ASND is $106.32M
What is the all time high quarterly SGA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly SGA is $106.32M
What is Ascendis Pharma A/S quarterly SGA year-on-year change?
Over the past year, ASND quarterly SGA has changed by +$33.78M (+46.57%)
What is Ascendis Pharma A/S TTM SGA?
The current TTM SGA of ASND is -$5.72B
What is the all time high TTM SGA for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM SGA is $556.61M
What is Ascendis Pharma A/S TTM SGA year-on-year change?
Over the past year, ASND TTM SGA has changed by -$6.01B (-2113.65%)